Besides, administration of the IFN-β-overexpressing MSCs caused a significant reduction in the tumor volume in prostate cancer lung metastasis in xenograft model (Ren et al., 2008b) and also squamous cell carcinoma xenograft model (Du et al., 2019). This evidence concerns the gene IFNB1 and neoplasm.